CIK 0001395064 · Large accelerated filer
TAKEDA PHARMACEUTICAL CO LTD
Sign in to watch- Ticker
- TKPHF
- Exchange
- NYSE, OTC
- Industry
- Pharmaceutical Preparations
- Entity type
- other
- Phone
- 81332782111
- Business address
- 1-1, NIHONBASHI-HONCHO 2-CHOME, CHUO-KU, TOKYO, Japan, 103-8668
Securities
- TAK Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) NYSE
- TKPHF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,523,173
- in 6 filings, $2.5M under 10b5-1 plans
Net −$5,523,173. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Plump Andrew Stewart −$2.5M President, R&D sold 48% of stake
- Platford Giles Richard −$1.2M President, IBU sold 17% of stake
- Bitetti Teresa Marie −$974K President, OBU sold 18% of stake
- Duprey Lauren Rusckowski −$640K Chief Transformation Officer sold 15% of stake
- Greenway Nicola Deidre Petal −$235K Chief Human Resources Officer sold 24% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-10 | Greenway Nicola Deidre Petal Chief Human Resources Officer | Sale | −975 | $17.50 | $17K | 93,431 |
| 2026-08-10 | Greenway Nicola Deidre Petal Chief Human Resources Officer | Sale | −33,628 | $17.51 | $589K | 59,803 |
| 2026-07-10 | GILLIS STEVEN Director | Returned to the company · Tax Obligation Award | −1,152 | $4,931.20 | $5.7M | 0 |
| 2026-07-10 | MARAGANORE JOHN Director | Returned to the company · Tax Obligation Award | −1,152 | $4,931.20 | $5.7M | 0 |
| 2026-07-10 | Reed Kimberly A. Director | Returned to the company · Tax Obligation Award | −1,152 | $4,931.20 | $5.7M | 0 |
| 2026-07-10 | Iijima Masami Director | Returned to the company · Tax Obligation Award | −2,152 | $4,931.20 | $10.6M | 0 |
| 2026-07-10 | Tsusaka Miki Director | Returned to the company · Tax Obligation Award | −2,152 | $4,931.20 | $10.6M | 0 |
| 2026-07-10 | Miyabashira Asuka President, Japan Pharma B.U. | Returned to the company · Tax Obligation Award | −1,022 | $4,931.40 | $5.0M | 0 |
| 2026-07-10 | Furuta Milano Chief Financial Officer | Returned to the company · Tax Obligation Award | −16,619 | $4,931.50 | $82.0M | 0 |
| 2026-07-01 | GILLIS STEVEN Director | Grant or award | +3,800 | 10,400 | ||
| 2026-07-01 | GILLIS STEVEN Director | Grant or award · Tax Obligation Award | +1,319 | 1,319 | ||
| 2026-07-01 | MARAGANORE JOHN Director | Grant or award | +3,800 | 10,400 | ||
| 2026-07-01 | MARAGANORE JOHN Director | Grant or award · Tax Obligation Award | +1,319 | 1,319 | ||
| 2026-07-01 | Reed Kimberly A. Director | Grant or award | +3,800 | 10,400 | ||
| 2026-07-01 | Reed Kimberly A. Director | Grant or award · Tax Obligation Award | +1,319 | 1,319 | ||
| 2026-07-01 | Iijima Masami Director | Grant or award | +1,800 | 14,601 | ||
| 2026-07-01 | Iijima Masami Director | Grant or award · Tax Obligation Award | +1,937 | 1,937 | ||
| 2026-07-01 | BROUSSARD BRUCE D Director | Grant or award | +3,800 | 4,595 | ||
| 2026-07-01 | BROUSSARD BRUCE D Director | Grant or award · Tax Obligation Award | +1,319 | 1,319 | ||
| 2026-07-01 | Stoffels Paulus Director | Grant or award | +3,800 | 3,800 |
Page 2 of 5 · 83 trades